AMRI has announced that it has completed construction of a new facility for chemical R & D in Budapest (Hungary). The completion and transfer to the 3,000 square feet of laboratory and administrative space represents an important milestone in the business plan initiated in 2008 to transform its central European business services discovery of higher value through the consolidation of several locations equipment and operating costs.
In addition to significant improvements in operational efficiencies and improved technology transfer, the new site provides capacity for the planned expansion of the synthetic chemistry, which currently is expected to double over the next five years.
"The completion of this expansion increases AMRI's ability to execute its strategy to accelerate growth and expand its presence in the European market," says Thomas E. D'Ambra, Ph.D., Chairman of the Board, CEO and President of the company. "He has been instrumental in deciding to carry out this project hope to create an enterprise customer base relatively untapped. We believe this latest investment, and our parallel investments in the U.S., India and Singapore, will strengthen the AMRI presence as a leading provider of a wide range of scientific services, capabilities and geographic choices throughout the world. "